Allschwil, Switzerland

Timo Rager

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Idorsia Pharmaceuticals Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timo Rager. Retrieved from https://idiyas.com/inventor/timo-rager-fvlofu7f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Timo Rager - Innovator in Pharmaceutical Science

Introduction

Timo Rager is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative work on clazosentan disodium salt.

Latest Patents

Timo Rager holds a patent for a stable crystalline hydrate of clazosentan disodium salt. This invention relates to a stable hydrate of clazosentan disodium salt, pharmaceutical formulations manufactured using the same, and their use as medicaments. His work in this area demonstrates a commitment to advancing medical treatments.

Career Highlights

Timo Rager is currently employed at Idorsia Pharmaceuticals Ltd., where he continues to push the boundaries of pharmaceutical research. His expertise and innovative mindset have positioned him as a valuable asset in the industry.

Collaborations

Timo collaborates with various professionals in his field, including his coworker Markus Von Raumer. Their combined efforts contribute to the development of groundbreaking pharmaceutical solutions.

Conclusion

Timo Rager's contributions to pharmaceutical science, particularly through his patent on clazosentan disodium salt, highlight his role as an innovator in the industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…